Apogem Capital LLC Iovance Biotherapeutics, Inc. Transaction History

Apogem Capital LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$16.55 - $27.63 $349,734 - $583,877	-21,132 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$20.35 - $26.63 $215,364 - $281,825	10,583 Added 100.32%	21,132 $521,000
Q2 2021 Aug 16, 2021	BUY	$16.33 - $33.07 $172,265 - $348,855	10,549 New	10,549 $274,000

313

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Apogem Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Apogem Capital LLC with notifications on news.